Porter, SR; Fedele, S; Habbab, KM; (2010) Xerostomia in head and neck malignancy. ORAL ONCOL , 46 (6) 460 - 463. 10.1016/j.oraloncology.2010.03.008.
Full text not available from this repository.
Xerostomia (dry mouth) as a consequence of treatment of head and neck malignancy is almost always due to radiotherapy. The resultant salivary gland dysfunction can adversely affect oral and systemic health as well as lessen quality of life. While the present management of radiotherapy-associated salivary dysfunction is challenging there have been striking advances in preventative strategies and a number of possible treatment options may be over the near horizon. (C) 2010 Published by Elsevier Ltd.
|Title:||Xerostomia in head and neck malignancy|
|Keywords:||Head and neck, Radiotherapy, Xerostomia, RADIATION-INDUCED XEROSTOMIA, INTENSITY-MODULATED RADIOTHERAPY, QUALITY-OF-LIFE, PAROTID-GLAND FUNCTION, STAGE NASOPHARYNGEAL CARCINOMA, SUBMANDIBULAR SALIVARY-GLANDS, VOLUME RESPONSE ANALYSIS, LOCALLY ADVANCED HEAD, SUBCUTANEOUS AMIFOSTINE, CANCER-PATIENTS|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Eastman Dental Institute > Maxillofacial, Diagnostic, Medical and Surgical Sciences|
Archive Staff Only: edit this record